Therapy is almost symptomatic and depends on the severity and extent of the hyperkeratosis. Topical management is indicated in mild forms include emollients, topical retinoids, and keratolytic. Systemic retinoids with doses considerably lower compared with those required for other disorders of cornification may be beneficial in some extensive and severe forms.

Recently, novel therapies targeting connexin hemichannels and gap junctions with a direct inhibitory action are being studied and may become available in the future.